Phio Pharmaceuticals (PHIO) Preferred Shares (2012 - 2016)

Phio Pharmaceuticals' (PHIO) quarterly Preferred Shares came in at $3.5 million in Q4 2016, down 23.7% on a QoQ basis from $4.6 million in Q1 2014.

Phio Pharmaceuticals (PHIO) Preferred Shares (2012 - 2016) Analysis & Trends

Phio Pharmaceuticals (PHIO) has 4 years of Preferred Shares data on file, last reported at $3.5 million in Q4 2016.

Quarterly Preferred Shares changed N/A year-over-year to $3.5 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $3.5 million (changed N/A YoY) and the FY2016 annual result came in at $3.5 million, changed N/A from the prior year.
Preferred Shares slipped to $3.5 million in Q4 2016, from $4.6 million in the prior quarter.
In the past five years, Preferred Shares ranged from a high of $9.6 million in Q3 2012 to a low of $2.0 million in Q3 2013.
A 4-year average of $5.8 million and a median of $4.6 million in 2014 frame the typical range for Preferred Shares.
The widest YoY moves for Preferred Shares: up 78.91% in 2013, down 78.91% in 2013.
Tracing PHIO's Preferred Shares over 4 years: stood at $9.6 million in 2012, then plunged by 78.91% to $2.0 million in 2013, then jumped by 128.83% to $4.6 million in 2014, then declined by 23.7% to $3.5 million in 2016.
The last three Preferred Shares figures came in at $3.5 million (Q4 2016), $4.6 million (Q1 2014), and $2.0 million (Q3 2013), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	-
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-
10	Phio Pharmaceuticals	14.06 Mn	14.06 Mn	-	-

Download Data